1995
DOI: 10.1016/0002-9378(95)90100-0
|View full text |Cite
|
Sign up to set email alerts
|

Pyelonephritis in pregnancy: Once-a-day ceftriaxone versus multiple doses of cefazolin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(16 citation statements)
references
References 5 publications
0
16
0
Order By: Relevance
“…Three studies provided data on spontaneous preterm birth before 37 weeks' gestation and/or neonatal intensive care admissions. 402,405,406 Data for at least one of these outcomes were available on the following comparisons: Only one study was found for each comparison, with one study 406 contributing to three of the comparisons. There were no significant differences between antibiotic regimens in incidence of spontaneous preterm birth before 37 weeks (Figures 113-117), or in admission to neonatal intensive care units (Figures 118-120), or in other perinatal and maternal outcomes ( Table 6).…”
Section: Antibiotics For Symptomatic Urinary Tract Infectionsmentioning
confidence: 99%
“…Three studies provided data on spontaneous preterm birth before 37 weeks' gestation and/or neonatal intensive care admissions. 402,405,406 Data for at least one of these outcomes were available on the following comparisons: Only one study was found for each comparison, with one study 406 contributing to three of the comparisons. There were no significant differences between antibiotic regimens in incidence of spontaneous preterm birth before 37 weeks (Figures 113-117), or in admission to neonatal intensive care units (Figures 118-120), or in other perinatal and maternal outcomes ( Table 6).…”
Section: Antibiotics For Symptomatic Urinary Tract Infectionsmentioning
confidence: 99%
“…Second-or third-generation cephalosporins may also be considered for single-agent therapy [1]. With these treatment regimens, more than 95% of women will respond within 72 hours [43,44]. Resistant organisms must be considered in women who do not respond appropriately to treatment, and antimicrobials should be changed according to culture results.…”
Section: Treatmentmentioning
confidence: 99%
“…The rise of extended spectrum β-lactamase (ESBL)-producing bacteria is compounding the problem, because antimicrobials such as the cephalosporins, which have a good safety profile in pregnant women, are rendered ineffective. Only four randomized control trials in pregnant women including 90,20 178,21 179,22 and 101,23 or 548 women in total, have assessed antimicrobial efficacy. These studies concluded that in non-bacteremic patients, oral cephalexin (500 mg every 6 hours) did not differ in efficacy and safety from intravenous (IV) cephalothin (1 g every 6 hours) treatment20; one time daily IV ceftriaxone was as effective as multiple daily doses of cefazolin 22.…”
Section: Introductionmentioning
confidence: 99%
“…Only four randomized control trials in pregnant women including 90,20 178,21 179,22 and 101,23 or 548 women in total, have assessed antimicrobial efficacy. These studies concluded that in non-bacteremic patients, oral cephalexin (500 mg every 6 hours) did not differ in efficacy and safety from intravenous (IV) cephalothin (1 g every 6 hours) treatment20; one time daily IV ceftriaxone was as effective as multiple daily doses of cefazolin 22. No difference in clinical response was observed with IV ampicillin and gentamicin, IV cefazolin, or intramuscular ceftriaxone,23 whereas cefuroxime (750 mg every 8 hours IV) was more efficacious and better tolerated than cephradine (1 g every 6 hours IV) 21.…”
Section: Introductionmentioning
confidence: 99%